Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases

Dutch cohort study reported improved overall survival with adjuvant systemic chemotherapy vs active surveillance (n=393; median, 39.2 vs 24.8 months; adjusted HR, 0.66; 95% CI, 0.49-0.88; P = 0.006).

Source:

JAMA Oncology